Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.

ABSTRACT:

Objective

Screening for hepatitis B virus (HBV) before chemotherapy is recommended by international guidelines; still, the HBV screening rate is low, and patients remain at risk for HBV reactivation (HBVr). Because HBVr is a serious and preventable condition, we conducted a survey to evaluate the screening behaviour of oncologists in the Netherlands.

Methods

We conducted an anonymous digital survey by email to all practicing medical oncologists. The surveys were sent in two session, the first one in 2017 and the second one in 2019. Questions included HBV screening procedures, reasons for screening and experience with HBVr.

Results

Among the 110 respondents, 29 (27%) followed a standardised protocol. Overall, 13 (12%) oncologists screened all patients, 76 (70%) only sc

SUBMITTER: Leber K 

PROVIDER: S-EPMC9285452 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature